Bill > SB1314

This bill updates health insurance coverage requirements for prostate cancer screenings across various health care plans in Virginia. Specifically, the bill modifies existing language to replace references to "PSA testing" with the broader term "prostate cancer screening," which now explicitly includes both prostate-specific antigen (PSA) tests and digital rectal examinations. The bill applies to health insurance policies for state employees, small employer group plans, and the state medical assistance services plan. It requires coverage for prostate cancer screenings for individuals age 50 and older, as well as those age 40 and older who are at high risk, based on the most recent American Cancer Society guidelines. Notably, the bill adds a new provision that insurers cannot impose deductibles, coinsurance, copayments, or other cost-sharing requirements for these screenings, with a narrow exception to maintain health savings account eligibility. The changes will take effect for contracts, policies, and plans delivered, issued, or renewed on or after January 1, 2026, ensuring a smooth transition for health care providers and insurers. This update aims to make prostate cancer screenings more accessible and affordable for Virginia residents by removing potential financial barriers to preventive care.